Cite
HARVARD Citation
von Herrath, M. et al. (2021). Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 9 (4), pp. 212-224. [Online].